Evonik Industries AG has opened a new lab at its Hanau site in Germany for highly potent active pharmaceutical ingredients (HPAPI) and expanded its cGMP capacity for HPAPI on a kilogram scale at Tippecanoe Labs in Lafayette, IN. The new lab allows Evonik to develop and optimize syntheses for HPAPI in Germany. At the U.S. site, Evonik has similar lab installations, expanding capacity with a reactor volume for HPAPI totalling 170 m3. Of this volume, approximately 135 m3 are being used for the prod...